Mobbs, 50, is alleged to have 'taken matters into her own hands' and tried three times to administer drugs through David ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Martin Ashburn, who runs The Escape Key in Newcastle, was diagnosed with Motor Neurone Disease in December 2023 ...

Motor neuron disease (MND), often referred to by the name of one of its varieties, ALS, is a degenerative condition that ...

Vigil on April 19, parishes across the U.S. will welcome thousands of new Catholics -- and this year, numbers are notably on ...

Findings challenge the idea that neurons follow a single learning strategy and offer a new perspective on how the brain ...

Amyotrophic lateral sclerosis (ALS) is a relatively rare but very serious disease of the nervous system. A cure is not yet ...

A Series in The Lancet Neurology provides state-of-the-art reviews covering clinical and scientific evidence on the four most common genetic subtypes of amyotrophic lateral sclerosis (ALS), caused by ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...